Acadia Healthcare Company (ACHC) closed at $29.98 on October 16, 2026, down 3.4% from the previous close, on volume of 1,362,141 shares (30-day average 1,411,571).
Data as of October 16, 2026.
16-Oct-2026
Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Tue, 13-Oct 2:56 PM ET)
Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release
Business Wire (Tue, 13-Oct 9:00 AM ET)
Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
Business Wire (Fri, 25-Sep 4:05 PM ET)
Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference
Business Wire (Wed, 9-Sep 9:00 AM ET)
Business Wire (Fri, 4-Sep 5:54 PM ET)
PRNewswire (Fri, 31-Jul 10:00 AM ET)
Business Wire (Tue, 28-Jul 4:05 PM ET)
Market Chameleon (Wed, 25-Feb 6:14 AM ET)
Acadia Healthcare Appoints Debbie Osteen as CEO, Reaffirms 2025 Guidance Amid Leadership Transition
Market Chameleon (Tue, 20-Jan 6:06 AM ET)
Acadia Healthcare Reaffirms 2025 Outlook as Debbie Osteen Returns to Lead Company
Market Chameleon (Tue, 20-Jan 3:54 AM ET)
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
Acadia Healthcare Company trades on the NASDAQ stock market under the symbol ACHC.
As of October 16, 2026, ACHC stock price declined to $29.98 with 1,362,141 million shares trading.
ACHC has a beta of 0.27, meaning it tends to be less sensitive to market movements. ACHC has a correlation of 0.00 to the broad based SPY ETF.
ACHC has a market cap of $2.79 billion. This is considered a Mid Cap stock.
Last quarter Acadia Healthcare Company reported $866 million in Revenue and $.38 earnings per share. This beat revenue expectation by $20 million and exceeded earnings estimates by $.02.
In the last 3 years, ACHC traded as high as $87.77 and as low as $11.43.
The top ETF exchange traded funds that ACHC belongs to (by Net Assets): IJR, VTI, IWM, AVUV, VB.
ACHC has outperformed the market in the last year with a price return of +21.5% while the SPY ETF gained +15.9%. However, in the short term, ACHC had mixed performance relative to the market. It has underperformed in the last 3 months, returning -7.1% vs +1.4% return in SPY. But in the last 2 weeks, ACHC shares have fared better than the market returning +11.3% compared to SPY -0.1%.
ACHC support price is $30.20 and resistance is $31.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHC shares will trade within this expected range on the day.
